News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
761,705 Results
Type
Article (47280)
Company Profile (641)
Press Release (713784)
Multimedia
Podcasts (82)
Webinars (13)
Section
Business (222142)
Career Advice (2705)
Deals (38543)
Drug Delivery (116)
Drug Development (86465)
Employer Resources (186)
FDA (17379)
Job Trends (16448)
News (375247)
Policy (35859)
Tag
Academia (2697)
Academic (1)
Accelerated approval (5)
Adcomms (24)
Allergies (95)
Alliances (53901)
ALS (106)
Alzheimer's disease (1472)
Antibody-drug conjugate (ADC) (155)
Approvals (17350)
Artificial intelligence (288)
Autoimmune disease (29)
Automation (17)
Bankruptcy (400)
Best Places to Work (12297)
BIOSECURE Act (22)
Biosimilars (114)
Biotechnology (438)
Bladder cancer (85)
Brain cancer (30)
Breast cancer (304)
Cancer (2443)
Cardiovascular disease (201)
Career advice (2263)
Career pathing (34)
CAR-T (169)
Cell therapy (472)
Cervical cancer (21)
Clinical research (70240)
Collaboration (926)
Company closure (2)
Compensation (584)
Complete response letters (28)
COVID-19 (2793)
CRISPR (48)
C-suite (274)
Cystic fibrosis (106)
Data (2370)
Decentralized trials (2)
Denatured (21)
Depression (54)
Diabetes (292)
Diagnostics (6830)
Digital health (20)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (128)
Drug pricing (123)
Drug shortages (30)
Duchenne muscular dystrophy (101)
Earnings (93385)
Editorial (45)
Employer branding (24)
Employer resources (157)
Events (124392)
Executive appointments (784)
FDA (18792)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (814)
Gene editing (121)
Generative AI (26)
Gene therapy (350)
GLP-1 (832)
Government (4732)
Grass and pollen (6)
Guidances (156)
Healthcare (20039)
Huntington's disease (25)
IgA nephropathy (30)
Immunology and inflammation (148)
Indications (30)
Infectious disease (2948)
Inflammatory bowel disease (155)
Inflation Reduction Act (9)
Influenza (54)
Intellectual property (103)
Interviews (496)
IPO (17663)
IRA (48)
Job creations (4629)
Job search strategy (1889)
Kidney cancer (11)
Labor market (46)
Layoffs (558)
Leadership (23)
Legal (9015)
Liver cancer (80)
Lung cancer (342)
Lymphoma (161)
Machine learning (9)
Management (63)
Manufacturing (359)
MASH (82)
Medical device (14408)
Medtech (14413)
Mergers & acquisitions (21445)
Metabolic disorders (781)
Multiple sclerosis (88)
NASH (21)
Neurodegenerative disease (113)
Neuropsychiatric disorders (31)
Neuroscience (2080)
NextGen: Class of 2025 (7205)
Non-profit (4654)
Now hiring (41)
Obesity (416)
Opinion (267)
Ovarian cancer (82)
Pain (101)
Pancreatic cancer (91)
Parkinson's disease (160)
Partnered (23)
Patents (253)
Patient recruitment (119)
Peanut (50)
People (62653)
Pharmaceutical (132)
Pharmacy benefit managers (22)
Phase I (21900)
Phase II (30908)
Phase III (23093)
Pipeline (1401)
Policy (174)
Postmarket research (2727)
Preclinical (9310)
Press Release (71)
Prostate cancer (112)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (422)
Real estate (6735)
Recruiting (71)
Regulatory (24400)
Reports (51)
Research institute (2448)
Resumes & cover letters (437)
Rett syndrome (6)
RNA editing (5)
RSV (49)
Schizophrenia (81)
Series A (142)
Series B (93)
Service/supplier (27)
Sickle cell disease (58)
Special edition (19)
Spinal muscular atrophy (157)
Sponsored (31)
Startups (4117)
State (2)
Stomach cancer (15)
Supply chain (75)
Tariffs (54)
The Weekly (59)
Vaccines (792)
Venture capitalists (45)
Weight loss (288)
Women's health (37)
Worklife (20)
Date
Today (66)
Last 7 days (1000)
Last 30 days (3154)
Last 365 days (34469)
2025 (12409)
2024 (37503)
2023 (42278)
2022 (53611)
2021 (58259)
2020 (56781)
2019 (49681)
2018 (37700)
2017 (35273)
2016 (35219)
2015 (41209)
2014 (35171)
2013 (30055)
2012 (32046)
2011 (32504)
2010 (30450)
Location
Africa (866)
Alabama (61)
Alaska (7)
Arizona (252)
Arkansas (14)
Asia (44016)
Australia (7282)
California (6663)
Canada (2101)
China (573)
Colorado (286)
Connecticut (298)
Delaware (166)
Europe (97465)
Florida (975)
Georgia (219)
Hawaii (1)
Idaho (61)
Illinois (588)
India (30)
Indiana (340)
Iowa (12)
Japan (176)
Kansas (111)
Kentucky (26)
Louisiana (14)
Maine (70)
Maryland (966)
Massachusetts (5091)
Michigan (248)
Minnesota (429)
Mississippi (2)
Missouri (89)
Montana (30)
Nebraska (26)
Nevada (69)
New Hampshire (69)
New Jersey (1875)
New Mexico (31)
New York (1869)
North Carolina (1133)
North Dakota (9)
Northern California (2883)
Ohio (224)
Oklahoma (14)
Oregon (46)
Pennsylvania (1465)
Puerto Rico (14)
Rhode Island (36)
South America (1307)
South Carolina (26)
South Dakota (1)
Southern California (2471)
Tennessee (105)
Texas (989)
United States (25287)
Utah (199)
Virginia (170)
Washington D.C. (72)
Washington State (606)
West Virginia (3)
Wisconsin (69)
761,705 Results for "mcgraw hill companies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Co-Diagnostics, Inc. to Exhibit at BioUtah’s 2025 Life Sciences Day on the Hill
January 31, 2025
·
2 min read
Press Releases
Rose Hill Life Sciences Appoints Biopharma Veteran Jama Pitman as Strategic Advisor
May 5, 2025
·
2 min read
Biosenta Announces Engagement of Oak Hill Financial Inc.
Biosenta Inc. (CSE: ZRO) (“Biosenta” or the “Company”) announces that it has entered into an agreement with Oak Hill Financial Inc. (“Oak Hill”) to provide business
January 11, 2024
·
3 min read
Policy
Hemostemix Announces Engagement of Oak Hill Asset Management Inc.
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce the non-exclusive engagement of Oak Hill Asset Management Inc. (“OHAM”), an Exempt Market Dealer to provide capital markets advice related to the Company’s capital markets strategy.
March 8, 2024
·
7 min read
Press Releases
Oak Hill Bio Enters into Exclusive License Agreement with Roche to Obtain Global Rights for a Phase 3-Ready, Potential Best-in-Class Treatment for Individuals with Angelman Syndrome
April 15, 2025
·
4 min read
Business
Benson Hill Reports Solid Full-Year 2023 Financial Results, Strengthens Balance Sheet
Benson Hill, Inc. (NYSE:BHIL, the “Company” or “Benson Hill”), an ag-tech company unlocking the natural genetic diversity of plants, today announced operating and financial results for the year ended December 31, 2023.
March 14, 2024
·
25 min read
Lone Star Bio
7 Hills Pharma Receives $4.7MM Grant to Advance First-in-class Cell/Gene Therapy Technology into the Clinic
7 Hills Pharma Inc., a clinical-stage pharma company leveraging a novel mechanism of action to safely enhance the effectiveness of cancer immunotherapies, was awarded $4.7 million from the Cancer Prevention and Research Institute of Texas to support its cell/gene therapy development program.
June 3, 2024
·
5 min read
Press Releases
HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
May 9, 2025
·
4 min read
Business
Benson Hill Announces Date of Fourth Quarter and Full Year Earnings Release
Benson Hill, Inc. (NYSE: BHIL, the “Company” or “Benson Hill”), an ag tech company unlocking the natural genetic diversity of plants, announced today that it will release its financial results for the full year and fourth quarter ending Dec. 31, 2023, before the market opens on Thursday, March 14, 2024.
February 7, 2024
·
1 min read
Press Releases
HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress
March 31, 2025
·
5 min read
1 of 76,171
Next
